Advertisement
Home Tags Drug Safety

Tag: Drug Safety

CDC: Counterfeit Drugs From Online Pharmacies Pose Considerable Danger

0

Agency notes that counterfeit pills often contain fentanyl and methamphetamine

Carcinogen Benzene Can Form in Some Acne Treatments: Report

0
By Robin Foster HealthDay Reporter THURSDAY, March 7, 2024 (HealthDay News) -- Some acne treatments may banish blemishes but carry hidden dangers: A new report...

Cyberattack Stalls Prescription Dispensing at UnitedHealth

0
By Robin Foster HealthDay Reporter TUESDAY, Feb. 27, 2024 (HealthDay News) -- For nearly a week, prescription drug orders have been disrupted at thousands of...

Tejocote Supplements Sold Online at Amazon, Etsy May Contain Fatal Poison: FDA

0
By Dennis Thompson HealthDay Reporter FRIDAY, Jan. 5, 2024 (HealthDay News) -- Tejocote weight-loss supplements sold online through Amazon or Etsy could contain a highly...

Overdose Deaths Involving Counterfeit Pills Increasing in U.S.

0

Quarterly percentage of deaths more than doubled with evidence of counterfeit pill use from July to September 2019 to October to December 2021

Recent Increase Seen in Pediatric Benzonatate Exposure

0

77 percent of the cases of pediatric exposure reported to U.S. poison control centers were for unintentional exposure

Most Safety Signals Reported to FDA Lead to Regulatory Action

0

Regulatory actions by the FDA were corroborated by at least one relevant published research study for 17 of 57 resolved safety signals

Many Psychiatric Patients Are Getting Risky Drug Gabapentin ‘Off-Label’

0
By Amy Norton HealthDay Reporter MONDAY, Nov. 22, 2021 (HealthDay News) -- Most prescriptions for the medication gabapentin are for unapproved uses -- and many...
The pooled prevalence of preventable patient harm is 6 percent across a range of medical settings globally

About One in 20 Patients Exposed to Preventable Harm

0
Pooled prevalence of preventable patient harm was 6 percent; 12 percent was severe, led to death
Use of pantoprazole for up to three years to prevent upper gastrointestinal events in patients receiving anticoagulant therapy with aspirin and/or rivaroxaban has a similar safety profile to placebo except for an increased risk for enteric infections

PPI Use for Up to Three Years Safe During Anticoagulant Tx

0
Safety profile did not differ for pantoprazole versus placebo except greater risk for enteric infections